Five new members were recently elected to serve on the board of trustees of University of the Sciences in Philadelphia. The responsibilities of the University’s board include approving the University’s strategic plans and ensuring consistency with the institution’s mission and goals. Andrew Ferrara, Boston Healthcare; Dr. Leonard S. Jacob, Life Science Advisors; William S. Marth, Teva Pharmaceuticals–The Americas; and Mark Oley, Westwood Pharmacy, will serve as members at-large, while Rose Mary B. Hoy, Merck, is the alumni representative.
Andrew Ferrara P’61
Prior to Boston Healthcare, Andrew Ferrara served in a number of business areas in the United States and Europe in his 20-year tenure with Eli Lilly & Company. During his last four years at Eli Lilly, he was corporate director of new product planning and licensing. A 1961 graduate of the University, his line management experience included the management of pharmaceutical operations, including all aspects of marketing and sales, for both Lilly and Dista in France and a member of the board of Lilly Industries in the United Kingdom. In 1984, Mr. Ferrara co-found Polygen Corporation, a computer software company serving the chemical and pharmaceutical research industries, and initiated a number of research and licensing agreements with academic institutions and major healthcare corporations in the United States, Europe, and Japan. Since founding Boston Healthcare in 1993, he has been involved in the development of a number of companies.
Leonard S. Jacob, BI’70, HonDSc’08, MD, PhD
Since receiving his biology degree from Philadelphia College of Pharmacy and Science in 1970, Dr. Jacob has been responsible for developing seven prescribed drugs impacting human health. From 1980 to 1989, he served as worldwide vice president of SmithKline Pharmaceutical Co. and was a member of their Corporate Management Committee. For the past two decades, Dr. Jacob has been an entrepreneur, co-founding Genaera Corp. (formerly Magainin Pharmaceuticals), a biotechnology company, and InKine Pharmaceutical Co., a specialty pharmaceutical company that developed and commercialized gastrointestinal products which was acquired by Salix Pharmaceuticals, Inc. Dr. Jacob recently served as a non-executive chairman of Bradley Pharmaceuticals and currently is chairman for Life Science Advisors, Antares Pharma Inc., and Stay Awhile Resorts. Dr. Jacob was bestowed an honorary doctor of science degree by the University in 2008.
William S. Marth, MBA
William S. Marth is the president and CEO of Teva Pharmaceuticals–The Americas. Teva Pharmaceuticals is among the top 15 pharmaceutical companies in the world and is the leading generic pharmaceutical company. Marth most recently held the role of president and CEO of Teva North America, and prior to that, he worked in Teva's U.S. Generic's division, which included the role of president and CEO. Prior to joining Teva, Marth served in various roles in Bristol-Myers Squibb’s Apothecon division. Marth is a licensed pharmacist and serves on various boards, including The American Society for Health-System Pharmacists. He also served as Chairman of the Generic Pharmaceutical Association in 2008 and 2009.
Mark Oley P’83
Mark Oley is the CEO/president and founder of Westwood Pharmacy, one of the largest pharmacy suppliers to correctional facilities throughout the United States. He has a long and distinguished record of accomplishments in pharmacy, including retail managed care, long-term care, and the correctional industry. He has developed tools to measure utilization and accountability for large self-funded organizations. Oley, who graduated from Philadelphia College of Pharmacy and Sciences in 1983 with a pharmacy degree, served as gubernatorial appointments on the Virginia Board of Pharmacy for eight years (1998 to 2006). He was the chairman of the Virginia Board of Pharmacy and is currently vice chair of the Virginia Medicaid Preferred Drug List. An active member of his community, Oley has been a consultant to the Virginia Home for Boys and a board member of both the American Heart Association and the Arthritis Foundation as well as the Henrico Education Foundation.
Rose Mary B. Hoy, P’82, RPh
Rose Mary Battista Hoy is currently the executive director of pharmacy and distribution in Merck's managed markets unit. In this role, she leads a team of national account executives and customer managers to support the profession of pharmacy, and to develop and enhance long-term business relationships with wholesalers, community pharmacy, convenient care clinics, and long-term care pharmacy. Hoy has been with Merck for 28 years, with previous responsibilities in sales, marketing, and manufacturing. She received her pharmacy degree from Philadelphia College of Pharmacy and Science in 1982, and also attended the Wharton School of Business. Hoy actively supports the USciences student chapter of the Academy of Managed Care Pharmacy in her role as diplomat, and she frequently lectures to students about careers in pharmacy.